SeaDragon Limited provided earnings guidance for the full year to March 31, 2017. For the year the company expects normalised EBITDA to be in the range of a loss of NZD 4.3 million to NZD 4.5 million compared to result of loss of NZD 0.4 million a year ago. This result is a reflection of the time it has taken to transition the business from its legacy Omega-2 business to Omega-3 fish oils refined in the new refinery. The transition of the business is now substantially complete, with approximately 95% of all saleable inventory of legacy products now sold.